Radiation induced brachial plexopathies

References

• Johansson K, Ohlsson K, Ingvar C, Albertsson M, Ekdahl C. Factors associated with the development of arm lymphedema following breast cancer treatment: A match pair case-control study. Lymphology 2002; 35: 59–71
   PubMed Web of Science ®Google Scholar
• van der Veen P, De Voogdt N, Lievens P, Duquet W, Lamote J, Sacre R. Lymphedema development following breast cancer surgery with full axillary resection. Lymphology 2004; 37: 206–8
   PubMedGoogle Scholar
• Chen AM, Obedian E, Haffty BG. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J 2001; 7: 480–91
   PubMed Web of Science ®Google Scholar
• Phan C, Mindrum M, Silverman C, Paris K, Spanos W. Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J 2003; 9: 461–6
   PubMedGoogle Scholar
• Bernier J, Thames HD, Smith CD, Horiot JC. Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy. Radiother Oncol 1998; 47: 137–43
   PubMed Web of Science ®Google Scholar
• Gillette EL, Mahler PA, Powers BE, Gillette SM, Vujaskovic Z. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys 1995; 31: 1309–18
   PubMed Web of Science ®Google Scholar
• van der Kogel AJ. Dose-volume effects in the spinal cord. Radiother Oncol 1993; 29: 105–9
   PubMedGoogle Scholar
• Denekamp J. Cell kinetics and radiation biology. Int J Radiat Biol Relat Stud Phys Chem Med 1986; 49: 357–80
   PubMed Web of Science ®Google Scholar
• Rubin DI, Schomberg PJ, Shepherd RF, Panneton JM. Arteritis and brachial plexus neuropathy as delayed complications of radiation therapy. Mayo Clin Proc 2001; 76: 849–52
   PubMedGoogle Scholar
• Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol 2005; 44: 13–22
   PubMed Web of Science ®Google Scholar
• Johansen J, Bentzen SM, Overgaard J, Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 1996; 40: 101–9
   PubMed Web of Science ®Google Scholar
• Peters LJ. Radiation therapy tolerance limits. For one or for all?–Janeway Lecture. Cancer 1996; 77: 2379–85
   PubMed Web of Science ®Google Scholar
• Thames HD, Jr. Effect-independent measures of tissue responses to fractionated irradiation. Int J Radiat Biol Relat Stud Phys Chem Med 1984; 45: 1–10
   PubMed Web of Science ®Google Scholar
• Jephcott CR, Tyldesley S, Swift CL. Regional radiotherapy to axilla and supraclavicular fossa for adjuvant breast treatment: A comparison of four techniques. Int J Radiat Oncol Biol Phys 2004; 60: 103–10
   PubMed Web of Science ®Google Scholar
• Hoeller U, Bonacker M, Bajrovic A, Alberti W, Adam G. Radiation-induced plexopathy and fibrosis. Is magnetic resonance imaging the adequate diagnostic tool?. Strahlenther Onkol 2004; 180: 650–4
   PubMedGoogle Scholar
• Ahmad A, Barrington S, Maisey M, Rubens RD. Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients. Br J Cancer 1999; 79: 478–82
   PubMedGoogle Scholar
• Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995; 31: 1093–112
   PubMed Web of Science ®Google Scholar
• Cohen L, Svensson H. Cell population kinetics and dose-time relationships for post-irradiation injury of the brachial plexus in man. Acta Radiol Oncol Radiat Phys Biol 1978; 17: 161–6
   PubMed Web of Science ®Google Scholar
• Olsen NK, Pfeiffer P, Mondrup K, Rose C. Radiation-induced brachial plexus neuropathy in breast cancer patients. Acta Oncol 1990; 29: 885–90
   PubMed Web of Science ®Google Scholar
• Powell S, Cooke J, Parsons C. Radiation-induced brachial plexus injury: Follow-up of two different fractionation schedules. Radiother Oncol 1990; 18: 213–20
   PubMed Web of Science ®Google Scholar
• Thames HD, Jr, Withers HR, Peters LJ, Fletcher GH. Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982; 8: 219–26
   PubMed Web of Science ®Google Scholar
• Kuhnt T, Richter C, Enke H, Dunst J. Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy. Strahlenther Onkol 1998; 174: 257–61
   PubMedGoogle Scholar
• Budach W, Classen J, Belka C, Bamberg M. Clinical impact of predictive assays for acute and late radiation morbidity. Strahlenther Onkol 1998; 174(Suppl 3)20–4
   PubMedGoogle Scholar
• Popanda O, Ebbeler R, Twardella D, Helmbold I, Gotzes F, Schmezer P, et al. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 1216–25
   PubMed Web of Science ®Google Scholar
• Andreassen, G, Cautte. Risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles. Acta Oncol 2005, (in press).
   PubMedGoogle Scholar
• Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction–II: Comparison of the effects of daily and twice-a-week fractionation on human skin. Int J Radiat Oncol Biol Phys 1984; 10: 599–606
   PubMed Web of Science ®Google Scholar
• Willers H, Beck-Bornholdt HP. Origins of radiotherapy and radiobiology: Separation of the influence of dose per fraction and overall treatment time on normal tissue damage by Reisner and Miescher in the 1930s. Radiother Oncol 1996; 38: 171–3
   PubMed Web of Science ®Google Scholar
• Langberg CW, Waldron JA, Baker ML, Hauer-Jensen M. Significance of overall treatment time for the development of radiation-induced intestinal complications. An experimental study in the rat. Cancer 1994; 73: 2663–68
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Dische S. Morbidity related to axillary irradiation in the treatment of breast cancer. Acta Oncol 2000; 39: 337–47
   PubMed Web of Science ®Google Scholar
• Wallgren A. Late effects of radiotherapy in the treatment of breast cancer. Acta Oncol 1992; 31: 237–42
   PubMed Web of Science ®Google Scholar
• Bajrovic A, Rades D, Fehlauer F, Tribius S, Hoeller U, Rudat V, et al. Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?. Radiother Oncol 2004; 71: 297–301
   PubMed Web of Science ®Google Scholar
• Johansson S, Svensson H, Larsson LG, Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients–a long-term follow-up. Acta Oncol 2000; 39: 373–82
   PubMed Web of Science ®Google Scholar
• Kogelnik HD. Influence of dose-time relationship on the pathogenesis of peripheral neuropathy (author's transl). Strahlentherapie 1977; 153: 467–9
   PubMedGoogle Scholar
• Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: Therapeutic perspective via the antioxidant pathway. Radiother Oncol 2004; 73: 119–31
   PubMed Web of Science ®Google Scholar
• Pritchard J, Anand P, Broome J, Davis C, Gothard L, Hall E, et al. Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy. Radiother Oncol 2001; 58: 279–86
   PubMed Web of Science ®Google Scholar
• Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353: 1641–8
   PubMed Web of Science ®Google Scholar
• Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956–62
   PubMed Web of Science ®Google Scholar
• Björk-Eriksson T, Glimelius B. The potential pf proton beam radiation therapy in breast cancer. Acta Oncol 2005; 44: 884–9
   PubMed Web of Science ®Google Scholar
• Ellerbroek N, Martino S, Mautner B, Tao ML, Rose C, Botnick L. Breast-conserving therapy with adjuvant paclitaxel and radiation therapy: Feasibility of concurrent treatment. Breast J 2003; 9: 74–8
   PubMedGoogle Scholar
• Moller TR, Brorsson B, Ceberg J, Frodin JE, Lindholm C, Nylen U, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 2003; 42: 387–410
   PubMed Web of Science ®Google Scholar
• Moller TR, Einhorn N, Lindholm C, Ringborg U, Svensson H. Radiotherapy and cancer care in Sweden. Acta Oncol 2003; 42: 366–75
   PubMed Web of Science ®Google Scholar
• Galecki, J, Hicer-Grzenkowicz, J, Grudzien-Kowalska, M, Michalska, T, Zalucki, W. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer-A Review. Acta Oncol 2006; 45: 280–4.
   PubMed Web of Science ®Google Scholar
• Fowler JF. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 2005; 44: 265–76
   PubMed Web of Science ®Google Scholar
• Glatstein E. Personal thoughts on normal tissue tolerance, or, what the textbooks don't tell you. Int J Radiat Oncol Biol Phys 2001; 51: 1185–9
   PubMedGoogle Scholar
• Hoeller U, Rolofs K, Bajrovic A, Berger J, Heesen C, Pfeiffer G, et al. A patient questionnaire for radiation-induced brachial plexopathy. Am J Clin Oncol 2004; 27: 1–7
   PubMedGoogle Scholar
• Johansson S, Svensson H, Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 2002; 52: 1207–19
   PubMed Web of Science ®Google Scholar
• Jung H, Beck-Bornholdt HP, Svoboda V, Alberti W, Herrmann T. Quantification of late complications after radiation therapy. Radiother Oncol 2001; 61: 233–46
   PubMed Web of Science ®Google Scholar